IPO

Why Not All IPOs Are Equally Profitable? The most successful and failed placements of shares on the stock exchange

What is an IPO?

Initial Public Offering (IPO) - initial public offering of shares on the stock exchange, as a result of which the company becomes recognizable, and also attracts funds.

At the same time, investors receive shares of the company among the first and most often with a discount to the offering price.. but, despite the discount, the acquisition of assets through an IPO carries high costs - payment of broker commissions, depository and tax contributions. This amount can reach 6-7% of the contract amount.

In the early hours, when there is increased demand, the growth of quotations can compensate for all costs and bring significant profits. However, this profit cannot be fixed., as the organizers set a lock-up period, or blocking period (3-6 months), when you can't sell shares, received during the placement. This is done in order, to exclude manipulation by large players.

Digital bank FinWise Bancorp postpones IPO

Цифровой банк finwise bancorp отложил ipo Цифровой банк FinWise Bancorp отложил IPO 1

Utah digital bank FinWise Bancorp, providing credit and deposit services throughout the United States, announced the decision to postpone the upcoming IPO. Earlier, the bank applied for attraction 58 million dollars, releasing 4,1 million shares (14% secondary) at a price from 13 to 15 dollars.

The developer of medical devices RenovoRx held an IPO

Разраб мед устройств renovorx провел ipo Разраб мед устройств RenovoRx провел IPO 5

RenovoRx company, which develops a honey device to heal decent tumors, attracted 17 million dollars, releasing 1,85 million packages of 9 dollars, low cost of the revised spectrum from 9 to 11 dollars. Each package consists of one ordinary share and one order, due on 10,80 dollars.

Altice-owned digital ad platform Teads withdrew IPO filing

Принадлежащая altice платформа цифровой рекламы teads отозвала заявку на ipo Принадлежащая Altice платформа цифровой рекламы Teads отозвала заявку на IPO 7

Teads company, spun off from Altice to offer advertisers and publishers a digital advertising platform, announced the withdrawal of the application for IPO. Initially, the company applied for attraction 751 million dollars, releasing 38,5 million shares (100% insider) at a price from 18 to 21 dollar, however, postponed the placement of shares at the end of July.

Medical device developer RenovoRx held an IPO

Разработчик медицинских устройств renovorx провел ipo Разработчик медицинских устройств RenovoRx провел IPO 9

RenovoRx company, developing a medical device for the treatment of solid tumors, attracted 17 million dollars, releasing 1,85 million packages of 9 dollars, minimum price of the revised range from 9 to 11 dollars. Each package consists of one ordinary share and one order, due on 10,80 dollars.

SeqLL Molecular Sequencer IPO

Молекулярный секвенсор seqll провел ipo Молекулярный секвенсор SeqLL провел IPO 11

SeqLL Company, developing molecular sequencing technology, attracted 13 million dollars, releasing 3,1 million packages of 4,75 dollar, average price of the stated range from 4,25 to 5,25 dollars. Each package includes one ordinary share

Surgical robot developer PROCEPT BioRobotics files for IPO

Разраб хирургических роботов procept biorobotics подал заявку на ipo Разраб хирургических роботов PROCEPT BioRobotics подал заявку на IPO 16

Компания PROCEPT BioRobotics, producing a surgical mechanized system for minimally invasive surgery in the field of urology, filed an application with the Securities and Exchange Commission to attract up to 100 million dollars.

Scroll up